C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/50 (2006.01) A61K 31/44 (2006.01) C07D 213/60 (2006.01) C07D 213/61 (2006.01) C07D 213/64 (2006.01)
Patent
CA 2252401
The invention encompasses the novel compound of Formula (I) as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula (I).
L'invention concerne le nouveau composé de la formule (I), ainsi qu'un procédé pour traiter les maladies à médiation par COX-2. Ce procédé consiste à administrer à un patient nécessitant ce type de traitement une quantité thérapeutiquement efficace, non toxique, d'un composé présentant la formule (I). L'invention concerne aussi certaines compositions pharmaceutiques pour le traitement des maladies à médiation par COX-2, comprenant les composés de la formule (I).
Black Cameron
Hughes Greg
Wang Zhaoyin
Merck Frosst Canada Inc.
Merck Frosst Canada Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1420619